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Almost two thousand millions of adults suffer from over-
weight or obesity in the world [1]. After decades of research,
we understand that the solution to this problem is not easy, as
the pernicious trend is still increasing [2].
This disease is defined as an excessive fat accumulation
together with a moderate but chronic inflammation [3].
This accompanying proinflammatory status is considered
the link between obesity and the development of its related
comorbidities such as insulin resistance and type 2 diabetes,
cardiovascular diseases, cancer, and nonalcoholic fatty liver
disease [4].
The main triggers for this inflammation have been tra-
ditionally considered oxygen tension, oxidative stress, and
endoplasmic reticulum stress [5]. This special issue con-
tains articles analyzing oxidative stress, adipokine secretory
pattern, methylation, or nanomedicine to further untangle
the processes involved in this disease and to offer promi-
sing/possible alternative therapeutical tools.
In this sense, D. Stygar and collaborators measured in
rats the levels of selected adipokines and other proteins, such
as FABP4, leptin, chemerin, and CRP, to show the proinflam-
matory effect of a high-fat diet. Interestingly, this effect was
reversed by the treatment of obesity with metabolic surgery.
As mentioned earlier, it seems clear the relation of an abnor-
mally enlarged adipose tissue and oxidative stress as it has
been analyzed in the article of Y. Gramlich and coworkers.
These authors suggest that obese patients undergoing coro-
nary artery bypass grafting showed altered myocardial redox
patterns, indicating an increased oxidative stress with inade-
quate antioxidant compensation. This might explain why
patients with high BMI suffering from coronary artery dis-
ease are more susceptible to cardiomyopathy and possible
damage by ischemia and reperfusion, for example, during
cardiac surgery. On the other hand, oxidative stress seems
to be related with diabetic retinopathy, one of the multiple
accompanying side-effects of obesity [6]. In this sense,
A. Maugeri and collaborators stated that hyperglycemia
increased ROS production and alters the DNA methylation
process, therefore altering the expression of certain genes.
They also found in their study that curcumin seems to reduce
oxidative stress and improves methylation activities, consid-
ering this compound an effective antioxidant to counteract
this condition. In the same area, another potent antioxidant
with self-regenerative properties, nanoparticles of cerium
oxide, was tested by A. Lopez-Pascual and coworkers in three
types of cells (adipocytes, macrophages, andmyotubes) under
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proinflammatory conditions. These nanoparticles showed a
mild insulin-sensitizing effect on murine adipocytes and
myotubes that needs to be further studied. Finally, in
another manuscript, M. Carreira et al. stated that Sirt6
expression could be a potential therapeutic target to counter-
act obesity-related liver diseases because it is downregulated
by the chronic low-grade inflammation and oxidative stress
induced by excess adiposity.
In conclusion, it is recognized worldwide that the main
predisposing factors to develop obesity are overconsumption
of calories and sedentary lifestyle, although the reality is quite
more complex [7]. These two options either together or indi-
vidually will lead to an abnormal enlarged adipose tissue,
accompanied by a proinflammatory status [8]. We have
known this for many years but without being able to tackle
the epidemy of obesity. Therefore, we need to understand
the molecular pathways involved in this pathological condi-
tion to provide new therapeutic tools, being the reason for
this special issue.
Conflicts of Interest
The authors declare that there is no conflict of interest







[1] World Health Organization, Obesity and Overweight, WHO,
2018, https://www.who.int/mediacentre/factsheets/fs311/en/.
[2] NCD Risk Factor Collaboration (NCD-RisC), “Trends in adult
body-mass index in 200 countries from 1975 to 2014: a pooled
analysis of 1698 population-based measurement studies with
19·2 million participants,” The Lancet, vol. 387, no. 10026,
pp. 1377–1396, 2016.
[3] N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in
inflammation and metabolic disease,” Nature Reviews Immu-
nology, vol. 11, no. 2, pp. 85–97, 2011.
[4] P. González-Muniesa, M. A. Mártinez-González, F. B. Hu et al.,
“Obesity,” Nature Reviews Disease Primers, vol. 3, article 17034,
2017.
[5] P. González-Muniesa, L. Garcia-Gerique, P. Quintero,
S. Arriaza, A. Lopez-Pascual, and J. A. Martinez, “Effects of
hyperoxia on oxygen-related inflammation with a focus on obe-
sity,” Oxidative Medicine and Cellular Longevity, vol. 2016,
Article ID 8957827, 11 pages, 2016.
[6] J. M. Santos, G. Mohammad, Q. Zhong, and R. A. Kowluru,
“Diabetic retinopathy, superoxide damage and antioxidants,”
Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 352–
361, 2011.
[7] D. Sellayah, F. R. Cagampang, and R. D. Cox, “On the evolu-
tionary origins of obesity: a new hypothesis,” Endocrinology,
vol. 155, no. 5, pp. 1573–1588, 2014.
[8] E. P. Williams, M.Mesidor, K. Winters, P. M. Dubbert, and S. B.
Wyatt, “Overweight and obesity: prevalence, consequences, and
causes of a growing public health problem,” Current Obesity
Reports, vol. 4, no. 3, pp. 363–370, 2015.
















































































Submit your manuscripts at
www.hindawi.com
